{"transactions":[{"id":4616172,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:18.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":121968,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":4.5,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":121968},"source":{"system":"sec-edgar","filing":"0001140361-26-036381","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036381/form4.xml","form_type":"4"}},{"id":4616171,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:18.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":103000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":2.25,"expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001140361-26-036381","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036381/form4.xml","form_type":"4"}},{"id":4616170,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:18.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":103000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.34,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001140361-26-036381","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036381/form4.xml","form_type":"4"}},{"id":4616169,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:18.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":64000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.88,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001140361-26-036381","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036381/form4.xml","form_type":"4"}},{"id":4616168,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:18.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":64000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":3.84,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001140361-26-036381","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036381/form4.xml","form_type":"4"}},{"id":4616167,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-11T21:44:18.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated as of July 15, 2026, by and among AtaiBeckley Inc. (the \"Company\"), Eli Lilly and Company, an Indiana corporation (\"Parent\"), and Albali Acquisition Corporation, a Delaware corporation and indirect wholly owned subsidiary of Parent (\"Merger Sub\"), on September 11, 2026, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each share of the Company's common stock, par value $0.01 per share, issued and outstanding immediately prior to the Effective Time, subject to certain exceptions, converted into the right to receive (i) $6.75 per share in cash, without interest, plus (ii) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-26-036381","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036381/form4.xml","form_type":"4"}},{"id":746594,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-09T00:00:32.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":121968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest on the earlier of the day before AtaiBeckley Inc.'s next annual meeting or June 4, 2027, subject to continued service on AtaiBeckley Inc.'s board of directors through the applicable vesting date."}],"balance_after":121968,"derivative":{"exercise_price":4.5,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":121968},"source":{"system":"sec-edgar","filing":"0001140361-26-024521","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126024521/form4.xml","form_type":"4"}},{"id":1099882,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-06-27T21:31:33.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":103000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest on the earlier of the day before the ATAI Life Sciences N.V's next annual meeting or June 26, 2026."}],"balance_after":103000,"derivative":{"exercise_price":2.25,"expiration_date":"2035-06-26","underlying":"Common Shares","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001140361-25-024023","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703767/000114036125024023/form4.xml","form_type":"4"}},{"id":1139328,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T23:03:36.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on May 20, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":142062,"source":{"system":"sec-edgar","filing":"0001104659-25-051710","document":"tm2515860-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465925051710/tm2515860-8_4seq1.xml","form_type":"4"}},{"id":1478436,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-06-14T21:00:43.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":103000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest on the earlier of the day before the ATAI Life Sciences N.V's next annual meeting or June 13, 2025."}],"balance_after":103000,"derivative":{"exercise_price":1.34,"expiration_date":"2034-06-13","underlying":"Common Shares","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001140361-24-030206","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703767/000114036124030206/form4.xml","form_type":"4"}},{"id":1504151,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T23:05:06.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":36111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on May 21, 2025, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective on May 13, 2022, the Issuer effected a 1-for-11 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":92062,"source":{"system":"sec-edgar","filing":"0001104659-24-064811","document":"tm2415466-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465924064811/tm2415466-2_4seq1.xml","form_type":"4"}},{"id":1878528,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T20:23:08.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":24715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on May 23, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":118316,"source":{"system":"sec-edgar","filing":"0001104659-23-064642","document":"tm2316982-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465923064642/tm2316982-5_4seq1.xml","form_type":"4"}},{"id":1877621,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-25T20:17:07.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest on the earlier of the day before the ATAI Life Sciences N.V's next annual meeting or May 16, 2024."}],"balance_after":64000,"derivative":{"exercise_price":1.88,"expiration_date":"2033-05-23","underlying":"Common Shares","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0000950170-23-024246","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703767/000095017023024246/ownership.xml","form_type":"4"}},{"id":2238095,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-09T20:32:04.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on June 7, 2023, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":93601,"source":{"system":"sec-edgar","filing":"0001104659-22-069684","document":"tm2218111-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465922069684/tm2218111-2_4seq1.xml","form_type":"4"}},{"id":2252672,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-27T21:55:11.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest on the earlier of the day before ATAI Life Sciences N.V.'s next annual meeting or May 25, 2023."}],"balance_after":64000,"derivative":{"exercise_price":3.84,"expiration_date":"2032-05-25","underlying":"Common Shares","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0000899243-22-019978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703767/000089924322019978/doc4.xml","form_type":"4"}},{"id":2571668,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-09-13T20:30:14.000Z","date":"2021-09-10","kind":"grant","acquired":true,"shares":128000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest with respect to a third of the underlying common shares on June 17, 2022 and in 24 substantially equal monthly installments thereafter until June 17, 2024."}],"balance_after":128000,"derivative":{"exercise_price":16.46,"expiration_date":"2031-09-10","underlying":"Common Shares","underlying_shares":128000},"source":{"system":"sec-edgar","filing":"0000899243-21-035675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703767/000089924321035675/doc4.xml","form_type":"4"}},{"id":2655478,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-06-24T20:16:18.000Z","date":"2021-06-22","kind":"purchase","acquired":true,"shares":4666,"price":15,"value":69990.0,"ownership":{"direct":true},"balance_after":4666,"source":{"system":"sec-edgar","filing":"0000899243-21-025739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703767/000089924321025739/doc4.xml","form_type":"4"}},{"id":2659404,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T21:26:15.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":72857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":72857,"derivative":{"exercise_price":0.9,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":72857},"source":{"system":"sec-edgar","filing":"0001628280-21-012671","document":"wf-form4_162439714172479.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828021012671/wf-form4_162439714172479.xml","form_type":"4"}},{"id":2659403,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-22T21:26:15.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,601 shares of common stock underlying unvested restricted stock units that vest on December 11, 2021, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":68601,"source":{"system":"sec-edgar","filing":"0001628280-21-012671","document":"wf-form4_162439714172479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828021012671/wf-form4_162439714172479.xml","form_type":"4"}},{"id":2944980,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Call Option (right to buy)","published_at":"2020-12-15T21:30:40.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":26042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest on December 11, 2021, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":26042,"derivative":{"exercise_price":1.12,"expiration_date":"2030-12-11","underlying":"Call Option (right to buy)"},"source":{"system":"sec-edgar","filing":"0001628280-20-017530","document":"wf-form4_160806782689725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828020017530/wf-form4_160806782689725.xml","form_type":"4"}},{"id":2944979,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-15T21:30:40.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":18601,"price":1.12,"value":20833.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on December 11, 2021, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":18601,"source":{"system":"sec-edgar","filing":"0001628280-20-017530","document":"wf-form4_160806782689725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828020017530/wf-form4_160806782689725.xml","form_type":"4"}},{"id":3137522,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-23T00:55:38.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":211111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"One-third of these restricted stock units are scheduled to vest on each of May 20, 2021, 2022 and 2023, assuming continued service through the applicable vesting date."}],"balance_after":211111,"source":{"system":"sec-edgar","filing":"0001104659-20-065544","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465920065544/a4.xml","form_type":"4"}},{"id":3137521,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-23T00:55:38.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":49143,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common stock of Assertio Holdings, Inc. (\"Issuer\") acquired at the effective time (\"Effective Time\") of the transactions contemplated in the Agreement and Plan of Merger, dated as of March 16, 2020 (the \"Merger Agreement\"), by and among Issuer, Zyla Life Sciences (\"Zyla\") and the other parties thereto.  Pursuant to the Merger Agreement, each share of Zyla common stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive, and became exchangeable for 2.5 shares of Issuer common stock.  Issuer common stock had a market value of approximately $0.80 per share at the close of market immediately prior to the Effective Time."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Additionally, all outstanding time-based restricted stock units of Zyla were cancelled and, in exchange therefor, each former holder of any such cancelled restricted stock unit has the right to receive a number of shares of fully vested Issuer common stock (rounded to the nearest whole number) equal to the product of (1) 2.5 and (2) the number of shares of Zyla common stock covered by such restricted stock unit."},{"field":"shares","element":"transactionShares","label":"F3","text":"Totals exclude shares withheld by the Issuer for applicable tax withholdings."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common stock of Assertio Holdings, Inc. (\"Issuer\") acquired at the effective time (\"Effective Time\") of the transactions contemplated in the Agreement and Plan of Merger, dated as of March 16, 2020 (the \"Merger Agreement\"), by and among Issuer, Zyla Life Sciences (\"Zyla\") and the other parties thereto.  Pursuant to the Merger Agreement, each share of Zyla common stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive, and became exchangeable for 2.5 shares of Issuer common stock.  Issuer common stock had a market value of approximately $0.80 per share at the close of market immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Additionally, all outstanding time-based restricted stock units of Zyla were cancelled and, in exchange therefor, each former holder of any such cancelled restricted stock unit has the right to receive a number of shares of fully vested Issuer common stock (rounded to the nearest whole number) equal to the product of (1) 2.5 and (2) the number of shares of Zyla common stock covered by such restricted stock unit."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Totals exclude shares withheld by the Issuer for applicable tax withholdings."}],"balance_after":49143,"source":{"system":"sec-edgar","filing":"0001104659-20-065544","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465920065544/a4.xml","form_type":"4"}},{"id":3138680,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T16:32:15.000Z","date":"2020-05-20","kind":"disposition_to_issuer","acquired":false,"shares":26953,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common stock and derivative securities of Zyla Life Sciences (\"Issuer\") were disposed of pursuant to the Agreement and Plan of Merger, dated as of March 16, 2020 (the \"Merger Agreement\"), by and among Issuer, Assertio Holdings, Inc. (\"Parent\"), Assertio Therapeutics, Inc., Alligator Merger Sub, Inc. and Zyla Merger Sub, Inc. (\"Merger Sub\"), pursuant to which each share of the Issuer's common stock issued and outstanding immediately prior to the effective time of the merger of Merger Sub with and into Issuer (the \"Effective Time\") was converted into the right to receive, and became exchangeable for, (1) 2.5 shares of Parent common stock for each share of Issuer's common stock and (2) any cash in lieu of fractional shares of Parent common stock.  Parent common stock had a market value of approximately $0.80 per share at the close of market immediately prior to the Effective Time."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Includes unvested time-based restricted stock units representing a contingent right to receive 26,953 shares of Issuer common stock upon vesting and settlement of such time-based restricted stock units.  At the Effective Time, all outstanding time-based restricted stock units of Issuer were cancelled and, in exchange therefor, each former holder of any such cancelled restricted stock unit has the right to receive a number of shares of fully vested Parent common stock (rounded to the nearest whole number) equal to the product of (1) 2.5 and (2) the number of shares of Issuer common stock covered by such restricted stock unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common stock and derivative securities of Zyla Life Sciences (\"Issuer\") were disposed of pursuant to the Agreement and Plan of Merger, dated as of March 16, 2020 (the \"Merger Agreement\"), by and among Issuer, Assertio Holdings, Inc. (\"Parent\"), Assertio Therapeutics, Inc., Alligator Merger Sub, Inc. and Zyla Merger Sub, Inc. (\"Merger Sub\"), pursuant to which each share of the Issuer's common stock issued and outstanding immediately prior to the effective time of the merger of Merger Sub with and into Issuer (the \"Effective Time\") was converted into the right to receive, and became exchangeable for, (1) 2.5 shares of Parent common stock for each share of Issuer's common stock and (2) any cash in lieu of fractional shares of Parent common stock.  Parent common stock had a market value of approximately $0.80 per share at the close of market immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Includes unvested time-based restricted stock units representing a contingent right to receive 26,953 shares of Issuer common stock upon vesting and settlement of such time-based restricted stock units.  At the Effective Time, all outstanding time-based restricted stock units of Issuer were cancelled and, in exchange therefor, each former holder of any such cancelled restricted stock unit has the right to receive a number of shares of fully vested Parent common stock (rounded to the nearest whole number) equal to the product of (1) 2.5 and (2) the number of shares of Issuer common stock covered by such restricted stock unit."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-064794","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000110465920064794/a4.xml","form_type":"4"}},{"id":3168144,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-04-28T19:40:12.000Z","date":"2020-04-23","kind":"exercise","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Stock Units convert into Common Stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 23, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 23, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date."}],"balance_after":13333,"derivative":{"underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001179110-20-005216","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911020005216/edgar.xml","form_type":"4/A","original_submission_date":"2020-04-24"}},{"id":3168143,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-28T19:40:12.000Z","date":"2020-04-23","kind":"tax_withholding","acquired":false,"shares":1805,"price":1.75,"value":3158.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to pay taxes applicable to vesting of restricted stock units."}],"balance_after":4862,"source":{"system":"sec-edgar","filing":"0001179110-20-005216","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911020005216/edgar.xml","form_type":"4/A","original_submission_date":"2020-04-24"}},{"id":3168142,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-28T19:40:12.000Z","date":"2020-04-23","kind":"exercise","acquired":true,"shares":6667,"price":1.75,"value":11667.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On April 23, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date."}],"balance_after":6667,"source":{"system":"sec-edgar","filing":"0001179110-20-005216","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911020005216/edgar.xml","form_type":"4/A","original_submission_date":"2020-04-24"}},{"id":3169958,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-04-24T18:13:02.000Z","date":"2020-04-23","kind":"exercise","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Stock Units convert into Common Stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 23, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 23, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date."}],"balance_after":13333,"derivative":{"underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001179110-20-005106","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911020005106/edgar.xml","form_type":"4"}},{"id":3169957,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T18:13:02.000Z","date":"2020-04-23","kind":"tax_withholding","acquired":false,"shares":952,"price":1.75,"value":1666.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to pay taxes applicable to vesting of restricted stock units."}],"balance_after":5715,"source":{"system":"sec-edgar","filing":"0001179110-20-005106","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911020005106/edgar.xml","form_type":"4"}},{"id":3169956,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T18:13:02.000Z","date":"2020-04-23","kind":"exercise","acquired":true,"shares":6667,"price":1.75,"value":11667.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On April 23, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date."}],"balance_after":6667,"source":{"system":"sec-edgar","filing":"0001179110-20-005106","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911020005106/edgar.xml","form_type":"4"}},{"id":3224090,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-05T20:43:00.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":13620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, which vest the day prior to the Company's annual meeting of stockholders to be held in 2021."}],"balance_after":13620,"source":{"system":"sec-edgar","filing":"0001179110-20-003203","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911020003203/edgar.xml","form_type":"4"}},{"id":3549885,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-24T20:52:48.000Z","date":"2019-04-23","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, which vest in three equal annual installments on the first three anniversaries of the date of grant."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001179110-19-005159","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911019005159/edgar.xml","form_type":"4"}},{"id":3676743,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-04T20:09:53.000Z","date":"2019-01-31","kind":"disposition_to_issuer","acquired":false,"shares":51817,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the First Amended Joint Plan of Reorganization filed by Egalet Corporation and its subsidiaries under Chapter 11 of the United States Bankruptcy Code (the \"Plan\"), the common stock and other equity interests of Egalet Corporation reported as disposed of herein were cancelled and retired and ceased to exist at the effective time of the Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the First Amended Joint Plan of Reorganization filed by Egalet Corporation and its subsidiaries under Chapter 11 of the United States Bankruptcy Code (the \"Plan\"), the common stock and other equity interests of Egalet Corporation reported as disposed of herein were cancelled and retired and ceased to exist at the effective time of the Plan."}],"balance_after":0,"derivative":{"exercise_price":3.67,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":51817},"source":{"system":"sec-edgar","filing":"0001179110-19-001264","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911019001264/edgar.xml","form_type":"4"}},{"id":3676742,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-04T20:09:53.000Z","date":"2019-01-31","kind":"disposition_to_issuer","acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the First Amended Joint Plan of Reorganization filed by Egalet Corporation and its subsidiaries under Chapter 11 of the United States Bankruptcy Code (the \"Plan\"), the common stock and other equity interests of Egalet Corporation reported as disposed of herein were cancelled and retired and ceased to exist at the effective time of the Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the First Amended Joint Plan of Reorganization filed by Egalet Corporation and its subsidiaries under Chapter 11 of the United States Bankruptcy Code (the \"Plan\"), the common stock and other equity interests of Egalet Corporation reported as disposed of herein were cancelled and retired and ceased to exist at the effective time of the Plan."}],"balance_after":0,"derivative":{"exercise_price":0.6,"expiration_date":"2028-05-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001179110-19-001264","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911019001264/edgar.xml","form_type":"4"}},{"id":3932421,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-15T16:19:56.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options to purchase shares of common stock vest 100% on the day prior to the date of the Corporation's annual meeting of stockholders to be held in 2019 subject to the director's continued service through the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":0.6,"expiration_date":"2028-05-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001179110-18-006810","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911018006810/edgar.xml","form_type":"4"}},{"id":4337441,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":40592,"kind":"person","name":"Smiley Andrea Heslin","position":1,"cik":"0001703767","reported_name":"Smiley Andrea Heslin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-02T16:40:51.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":51817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests with respect to one-fourth of the underlying shares on each of the first four anniversaries of the grant date."}],"balance_after":51817,"derivative":{"exercise_price":3.67,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":51817},"source":{"system":"sec-edgar","filing":"0001179110-17-006391","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911017006391/edgar.xml","form_type":"4"}}]}